12/8/2022  5:30:15 PM Chg. -9.00 Volume Bid5:40:00 PM Ask5:40:00 PM Market Capitalization Dividend Y. P/E Ratio
613.00CHF -1.45% 7,063
Turnover: 4.32 mill.
600.00Bid Size: 72 620.00Ask Size: 10 2.69 bill.CHF 0.52% 26.97

Business description

The Siegfried Group is a global life sciences company with facilities located in Switzerland, the USA, Malta, China, Germany and France. Siegfried is active in primary and secondary drug manufacturing. The company develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with R& D programs, related intermediates and controlled substances. Siegfried also offers development and production of finished dosage forms, including sterile fillings.
 

Management board & Supervisory board

CEO
Dr. Wolfgang Wienand
Management board
Dr. Reto Suter, Arnoud Michael Middel, Dr. Jürgen Roos, Irene Wosgien, Marcel Imwinkelried, Marianne Späne
Supervisory board
Alexandra Brand, Beat Walti, Colin Bond, Dr. Andreas Casutt, Dr. Martin Schmid, Isabelle Welton, Wolfram Carius
 

Company data

Name: Siegfried Holding AG
Address: Untere Brühlstraße 4,CH-4800 Zofingen
Phone: +41-62-746-1111
Fax: +41-62-746-1202
E-mail: info@siegfried.ch
Internet: www.siegfried.ch
Industry: Commodities
Sector: Chemicals
Sub sector: -
End of financial year: 12/31
Free Float: 75.10%
IPO date: -

Investor relations

Name: -
IR phone: +41-62-746-1148
IR Fax: -
IR e-mail: -

Main Shareholders

Freefloat
 
75.10%
Ernst Göhner Stiftung
 
6.60%
BlackRock, Inc.
 
3.30%
Norges Bank
 
3.00%
René Braginsky, Susanne Braginsky, David Braginsky; Zürich / Tel Aviv
 
3.00%
eigene Aktien
 
3.00%
Credit Suisse Funds AH
 
3.00%
Dimensional Holdings Inc., c/o Corporation Service Company
 
3.00%